Hutch News
New HIV vaccine trial to launch in U.S., Latin America and Europe
‘Mosaico’ will enroll 3,800 transgender people and men who have sex with men
Improving HIV clinical trials with mobile technology
From the HIV Vaccine Trials Network, Vaccine and Infectious Disease Division
Could an infant’s blood sample help model a better HIV vaccine?
Tracing the evolution of a baby’s special HIV-blocking protein
Increased racial and ethnic minority participation in HIV vaccine trials
From the HIV Vaccine Trials Network, Vaccine and Infectious Disease Division
The pride of Fred Hutch
HIV Vaccine Trials Network veteran Steven Wakefield named a grand marshal in Seattle Pride Parade
Meet Peru's HIV superhero
By finding a better way to prevent HIV, Dr. Jorge Sanchez aims to help end his country’s AIDS epidemic
10 highlights of Fred Hutch science in 2017
A look back at notable discoveries in cancer immunotherapy, HIV prevention and more
New HIV vaccine study launched for World AIDS Day
As lights around the world glow red today, Fred Hutch-based researchers lead global effort to end the pandemic
Enlisting the microbiome in the quest for an AIDS vaccine
We now know that microbial communities, especially in our guts, profoundly affect immune response
Good News: Stemming the harm common virus causes in critically ill patients
Celebrating faculty and staff achievements
Will the flu vaccine work for you? Answer may be in your genes
Set of 9 genes that predicts flu response in adults under 35 could be first step to personalized vaccine
Community-building leads to record enrollment in HIV prevention study
Fighting the stigma of HIV among communities of color takes trust — and time
Training tomorrow's HIV researchers
With no end yet to the pandemic, a program supports young South African physician-scientists
With Fred Hutch's HIV lab in South Africa, 'We've become full partners.'
An HIV laboratory in South Africa advances scientific understanding, and more
On World AIDS Day, renewed hope for an HIV vaccine
Clinical trial taking place in South Africa could 'dramatically alter the course of the pandemic’
Community is key for new, large HIV vaccine trial
Community trust is key as researchers start a new trial across 15 sites in South Africa
Good News: Dr. Oliver Press wins mentorship award; Seattle magazine names Dr. Larry Corey to Seattle's 'Hall of Fame'
Celebrating faculty and staff achievements
'Roz and Ray': An HIV tragedy with lessons for today
Seattle Repertory drama, panel explore fallout from an early AIDS crisis in hemophiliacs
Empowering ‘millions of women’ against HIV
AMP study in sub-Saharan Africa tests an antibody infusion that could put protection in women’s hands
Good News: Dr. David Maloney named cellular immunotherapy medical director at Fred Hutch, SCCA; Dr. Jim Kublin gets grant to study how gut bugs alter HIV vaccine response
Celebrating faculty and staff achievements
Hutch researcher, South African pediatrician recalls HIV hero Nkosi Johnson at AIDS 2016
At AIDS 2016, a South African pediatrician and Fred Hutch vaccine researcher pays tribute to a young HIV hero
Good News at Fred Hutch
Celebrating faculty and staff achievements
A virus researcher's 35 years in the AIDS trenches
After helping pave the way to HIV treatment, Dr. Larry Corey wants a vaccine — and a cure
Good News at Fred Hutch
Celebrating faculty and staff achievements